An open-label, flexible-dose trial of the safety and efficacy of Geodon [ziprasidone] in non-rapid-cycling bipolar II patients with major depression
Latest Information Update: 22 Jun 2013
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar II disorders
- Focus Therapeutic Use
- 12 May 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 03 Feb 2006 New trial record.